ProQR Therapeutics NV (PRQR)
1.84
-0.15
(-7.54%)
USD |
NASDAQ |
Apr 20, 16:00
1.86
+0.02
(+1.09%)
After-Hours: 06:53
ProQR Therapeutics EPS Diluted (Quarterly) : -0.1008 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -0.5949 |
| argenx SE | -- |
| Pharming Group NV | 0.0699 |
| Pharvaris NV | -0.8343 |
| NewAmsterdam Pharma Co. NV | -0.6549 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.38M |
| Revenue (Quarterly) | 5.456M |
| Total Expenses (Quarterly) | 15.84M |
| Enterprise Value | 101.76M |
| Gross Profit Margin (Quarterly) | 85.52% |
| Profit Margin (Quarterly) | -190.3% |
| Earnings Yield | -24.71% |
| Normalized Earnings Yield | -24.80 |